pyrroles has been researched along with Behavior Disorders in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Hoshikawa, Y; Hoshino, S; Iwakiri, K; Kawami, N | 1 |
| Chopp, M; Ding, C; Jiang, F; Jiang, J; Lu, Y; Yang, H; Zhang, L; Zhao, D; Zheng, X | 1 |
| CRAIG, JB; KAELBLING, R; PASAMANICK, B | 1 |
| Keller, PA; McCluskey, A; Morgan, J; O'connor, SM | 1 |
| Irvine, DG | 2 |
| Bayne, W; Irvine, DG; Majer, JR | 1 |
| Reio, L; Wetterberg, L | 1 |
2 review(s) available for pyrroles and Behavior Disorders
| Article | Year |
|---|---|
The role of the HPA axis in psychiatric disorders and CRF antagonists as potential treatments.
Topics: Amino Acid Sequence; Animals; Corticotropin-Releasing Hormone; Humans; Hypothalamo-Hypophyseal System; Mental Disorders; Molecular Sequence Data; Pituitary-Adrenal System; Pyrimidines; Pyrroles; Receptors, Corticotropin-Releasing Hormone | 2006 |
Kryptopyrrole and other monopyrroles in molecular neurobiology.
Topics: Animals; Anticonvulsants; Behavior, Animal; Bile Pigments; Blood-Brain Barrier; Chemical Phenomena; Chemistry; Chromatography; Electrophysiology; Humans; Mental Disorders; Molecular Conformation; Nervous System; Oxidation-Reduction; Porphyrias; Pyrroles; Rats | 1974 |
7 other study(ies) available for pyrroles and Behavior Disorders
| Article | Year |
|---|---|
Prevalence of behavioral disorders in patients with vonoprazan-refractory reflux symptoms.
Topics: Aged; Female; Gastroesophageal Reflux; Humans; Japan; Logistic Models; Male; Mental Disorders; Middle Aged; Prevalence; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Sulfonamides | 2021 |
Atorvastatin reduces functional deficits caused by photodynamic therapy in rats.
Topics: Animals; Astrocytes; Atorvastatin; Brain; Cell Line, Tumor; Cell Proliferation; Dihematoporphyrin Ether; Endothelial Cells; Glioma; Heptanoic Acids; Humans; Mental Disorders; Neovascularization, Physiologic; Neuroprotective Agents; Photochemotherapy; Pyrroles; Rats; Rats, Inbred F344; Synaptophysin; Vascular Endothelial Growth Factor A; von Willebrand Factor | 2011 |
Urinary porphobilinogen. Results of screening 2,500 psychiatric patients.
Topics: Humans; Mental Disorders; Porphobilinogen; Porphyrins; Pyrroles | 1961 |
[The (crypto-)pyrroluria in environmental medicine: a valid diagnosis? Report of the "Methods and Quality Assurance in Environmental Medicine" Committee] ].
Topics: Animals; Environmental Monitoring; Heme; Humans; Mental Disorders; Porphyrins; Pyrroles; Risk Factors | 2007 |
Pyrroles in neuropsychiatric and porphyric disorders: confirmation of a metabolite structure by synthesis.
Topics: Chromatography, Gel; Humans; Mental Disorders; Nervous System Diseases; Porphyrias; Pyrroles | 1978 |
Autotransfer chromatography combined with mass spectroscopy, for the characterization of pyrroles and indoles.
Topics: Chromatography; Humans; Indoles; Mental Disorders; Methods; Pyrroles; Spectrum Analysis | 1970 |
False porphobilinogen reactions in the urine of mental patients.
Topics: Chemical Phenomena; Chemistry; Chromatography; Coloring Agents; False Positive Reactions; Humans; Mental Disorders; Phenothiazines; Porphyrins; Pyrroles | 1969 |